home / stock / psnl / psnl news


PSNL News and Press, Personalis Inc. From 11/03/21

Stock Information

Company Name: Personalis Inc.
Stock Symbol: PSNL
Market: NASDAQ
Website: personalis.com

Menu

PSNL PSNL Quote PSNL Short PSNL News PSNL Articles PSNL Message Board
Get PSNL Alerts

News, Short Squeeze, Breakout and More Instantly...

PSNL - Notable earnings before Thursday's open

ABC, ABUS, ACIW, ADAP, AES, AHCO, AKBA, ALBO, ALE, APD, APTV, ARW, ASPS, ATNX, ATRA, ATRS, BCE, BDX, BLDR, BLI, BLL, BRG, BXRX, CARS, CCOI, CFX, CHH, CI, CLDT, CMRX, CNHI, CNP, CNQ, COMM, CPE, CS, CTXS, CWEN, CYBR, DBRG, DEN, DIN, DISH, DLX, DNB, DOCN, DUK, EPAM, ERJ, ESTE, EURN, EVA, FIS, FW...

PSNL - Personalis Announces Updates to NeXT Platform(TM) Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the latest expansion of the Personalis NeXT Platform® adding several new features that are key to the understanding of the interactions between the tumor and the immune system and how the...

PSNL - Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the issuance of two key US Patents related to its high-performance, exome-wide liquid biopsy platform, NeXT Liquid Biopsy ™ . The first patent, US Patent No. 11,142,802, entitle...

PSNL - Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the publication of its study “ Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation ,” in the Immunopeptidomics ...

PSNL - Personalis to Announce Third Quarter Financial Results on November 4, 2021

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today it will release its third quarter 2021 financial results before the market opens on Thursday, November 4, 2021. In conjunction with the release, the company will host a conference call and webcast...

PSNL - Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the appointment of Robert Bruce to the newly created position of Vice President of Reimbursement. “We are very pleased to welcome Bob and his impressive public and private payer reimbur...

PSNL - Cathie Wood Goes Bargain Shopping: 3 Sinking Stocks She Keeps Buying

What do the most successful investors do when their favorite stocks tank? If you're Cathie Wood, founder, and CEO of ARK Invest, you keep buying more. Shares of life-science equipment manufacturer Berkeley Lights (NASDAQ: BLI) took a hit last week, and two ARK Invest ETFs qu...

PSNL - Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced that the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP) has issued a new task order under its current contract with the company, with a value of up ...

PSNL - Cathie Wood Goes Dumpster Diving: 3 Beaten Down Stocks She Just Bought

I don't know about you, but the day after Labor Day has never been a very productive one. The same cannot be said for ARK Invest CEO and founder Cathie Wood. Yesterday, the collection of exchange-traded funds she manages were just as busy as ever. Wood confidently bought some healthcare...

PSNL - Personalis to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will participate at the Morgan Stanley 19 th Annual Global Healthcare Conference on Thursday, September 9, 2021 at 3:30 p.m. Eastern Time. About Personalis, Inc....

Previous 10 Next 10